why choose us

First received: August 17, 2022

Clinical Trial: Single Dose Glumetinib in Healthy Chinese Male Subjects

Study Status: Completed

Recruit Status: Completed

Condition: Healthy Volunteers

Study Type: Interventional


Official Title: A Clinical Study to Evaluate Food Effect on Pharmacokinetics and Safety After Single Dose Glumetinib in Healthy Chinese Male Subjects

Brief Summary: This is a phase I, single-center, randomized, open-label, single-dose, three-period (fasting, high-fat meal, low-fat meal) crossover clinical study to investigate the food effect on PK of the recommended phase II dose (RP2D) of 300 mg Glumetinib, based on the previous clinical studies of Glumetinib monotherapy.

Read more